Tom Skipper

Wang lab

Tom is originally from England and moved to Connecticut as a child. He graduated from Brown University in 2019 with a degree in biomedical engineering. Subsequent research focused on preclinical validation of new cancer targets at the Broad Institute. He is currently a third-year MD-PhD student in the Wang lab interested in cancer epigenetics and its application to precision medicine. When not at the bench or in the books, he enjoys reading, discovering new music, and anything that gets him outside including trail running, soccer, skiing, biking, and backpacking.

Contact

Thomas.A.Skipper.GR@dartmouth.edu
HB Hinman Box 7936

Selected Publications

  • Bondeson DP, Mullin-Bernstein Z, Oliver S, Skipper TA…Sellers WR, Ianari A. Systematic profiling of conditional degron tag technologies for target validation studies. Nat Commun. 2022 Sep 20;13(1):5495. doi: 10.1038/s41467-022-33246-4

    Bondeson DP, Paolella BR, Asfaw A, Rothberg MV, Skipper TA…Vazquez F, Golub TR. Phosphate dysregulation via the XPR1:KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer. Nat Cancer. 2022 Jun;3(6):681-695. doi: 10.1038/s43018-022-00360-7

    Neggers JE, Paolella BR, Asfaw A, Rothberg MV, Skipper TA…Golub TR, Vazquez F, Aguirre AJ. Synthetic lethal interaction between the ESCRT paralog enzymes VPS4A and VPS4B in SMAD4 or CDH1-deleted cancers. Cell Rep. 2021 Jul 13;36(2):109367. doi: 10.1016/j.celrep.2021.109367.